Regeneron
Mary Andrus possesses extensive experience in global patient safety systems and pharmacovigilance, currently serving as Director of Global Patient Safety Systems at Regeneron since November 2016, following roles as Associate Director and Senior Manager in the same field. Prior to Regeneron, Mary worked at Daiichi Sankyo, Inc. from June 2000 to October 2016 as PV Data Manager in Clinical Safety and Pharmacovigilance. Early career positions include Administrative Assistant in Cardiovascular Clinical Research at Bristol-Myers Squibb and Publicity Assistant roles at St. Martin's Press and Rutgers University Press. Mary holds a Bachelor of Arts in English Language and Literature from Rutgers University, earned in 1998.
This person is not in any teams
This person is not in any offices
Regeneron
130 followers
Regeneron Pharmaceuticals is focused on the development of pharmaceutical products for the treatment of serious medical conditions.